Long-term gastric changes in achlorhydric H+/K +-ATPase beta subunit deficient mice

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 1042-1047

  Bakkelund, Karin E ^a   Waldum, Helge L ^a,b   Nordrum, Ivar Skjk ^a,b   Hauso, Øyvind ^a,b   Fossmark, Reidar ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

ECL cell; Gastric cancer; Gastrin; Menetrier's disease; Proton pump inhibitors

Indexed keywords

ALBUMIN; GASTRIN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE;

ACHLORHYDRIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; FEMALE; HISTOPATHOLOGY; HYPERGASTRINEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MENETRIER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH GLAND; STOMACH PARIETAL CELL;

ACHLORHYDRIA; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC MUCOSA; GASTRITIS, HYPERTROPHIC; MICE; MICE, KNOCKOUT; TIME FACTORS;

EID: 77955520581     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.490952     Document Type: Article

References (34)

1. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986;35(Suppl 1):42-55.
2. Poynter D, Selway SA, Papworth SA, Riches SR. Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. Gut 1986;27: 1338-1346
3. Waldum H, Petersen H, Brenna E. Gastrin and gastric cancer. Eur J Gastroenterol Hepatol 1992;4:801-811
4. Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88:638-648
5. Zamcheck N, Grable E, Ley A, Normal L. Occurrence of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N Engl J Med 1955;252: 1103-1110
6. Cadiot G, Vissuzaine C, Potet F, Mignon M. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci 1995;40:1275-1278
7. Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P, et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999;319: 550-553
8. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996;39:649-653
9. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009;137:80-87
10. Bjornsson E, Abrahamsson H, Simren M, Mattsson N, Jensen C, Agerforz P, et al. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006;24:945-954
11. Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimura M, et al. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 1998;43: 253-257
12. Procter Gamble Company/Astra Zeneca L. Omeprazole magnesium tablets. NDA 2000;21:229.
13. Lamberts R, Creutzfeldt W, Stockmann F, Jacubaschke U, Maas S, Brunner G. Long-term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion 1988;39:126-135
14. Martinsen TC, Kawase S, Hkanson R, Torp SH, Fossmark R, Qvigstad G, et al. Spontaneous invasive ECL-omas in cotton rats are prevented by a gastrin receptor agonist. Carcinogenesis 2003;24:1887-1896
15. Scarff KL, Judd LM, Toh BH, Gleeson PA, Van Driel IR. Gastric H(+),K(+)-adenosine triphosphatase beta subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology 1999;117: 605-618
16. Kleveland PM, Haugen SE, Waldum HL. The preparation of bioactive 125I-gastrin, using iodo-gen as oxidizing agent, and the use of this tracer in receptor studies. Scand J Gastroenterol 1985;20:569-576
17. Sevier AC, Munger BL. A silver method for paraffin sections of neural tissue. J Neuropathol Exp Neurol 1965;24:130-135
18. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986;90:391-399
19. Korman MG, Strickland RG, Hansky J. Serum gastrin in chronic gastritis. Br Med J 1971;2:16-18.
20. Brenna E, Waldum HL. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship. Gut 1992;33:1303-1306
21. Waldum HL, Brenna E, Martinsen TC. Safety of proton pump inhibitors. Aliment Pharmacol Ther 2000;14:1537-1538
22. Franic TV, Judd LM, Robinson D, Barrett SP, Scarff KL, Gleeson PA, et al. Regulation of gastric epithelial cell development revealed in H(+)/K(+)-ATPase beta-subunit-and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001;281:G1502-11.
23. Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetriers disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest 1992;90:1161-1167
24. Kenney FD, Dockerty MB, Waugh JM. Giant hypertrophy of gastric mucosa: a clinical and pathological study. Cancer 1954;7:671-681
25. Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl 1992;194:1-7.
26. Lamers CB, Hafkenscheid JC, van Tongeren JH. Serum albumin levels in patients with the Zollinger-Ellison syndrome. Gastroenterology 1977;73:975-979
27. Stempien SJ, Dagardi AE, Reingold IM, Heiskell CL, Goodman JR, Bloom A, et al. Hypertrophic hypersecretory gastropathy. Analysis of 15 cases and a review of the pertinent literature. Am J Dig Dis 1964;9:471-493
28. Bakke I, Qvigstad G, Brenna E, Sandvik AK, Waldum HL. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta Physiol Scand 2000;169:29-37.
29. Fukui H, Kinoshita Y, Maekawa T, Okada A, Waki S, Hassan S, et al. Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 1998;115:1483-1493
30. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47.
31. Fieber SS, Rickert RR. Hyperplastic Gastropathy. Analysis of 50 selected cases from 1955-1980. Am J Gastroenterol 1981; 76:321-329
32. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006;24:1341-1348
33. Fossmark R, Jianu CS, Martinsen TC, Qvigstad G, Syversen U, Waldum HL. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Scand J Gastroenterol 2008;43:20-24
34. Aprile MR, Azzoni C, Gibril F, Jensen RT, Bordi C. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome. Hum Pathol 2000;31:140-148